International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“TTLC is approaching!
As you plan for the new year, this is a reminder that registration remains open for the 2026 IASLC Targeted Therapies of Lung Cancer (TTLC) Meeting.
TTLC brings together a global community focused on advancing targeted therapies in lung cancer through data-driven discussion, collaboration, and shared expertise.
If you plan to attend but haven’t registered yet, now is a good time to secure your spot.”
More posts about IASLC.